This research examines the effects of transitioning to automated insulin delivery systems on pediatric patients with type 1 diabetes.
Implemented a funding-driven transition to automated insulin delivery systems.
Provided structured education and follow-up support to participants.
Evaluated safety outcomes including episodes of diabetic ketoacidosis and hypoglycemia.
No episodes of diabetic ketoacidosis reported during the transition.
No level 3 hypoglycemia episodes observed among participants.
Statistically significant improvement in insulin delivery metrics (p=0.0012).
Abstract
= 0.0012), with no episodes of diabetic ketoacidosis or level 3 hypoglycemia. Funding-driven AID transitions can be safely implemented with structured education and follow-up.